Tandem Diabetes Care, Inc. Increase (Decrease) in Other Current Liabilities
Tandem Diabetes Care, Inc. (TNDM) reported Increase (Decrease) in Other Current Liabilities of $3.56 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2023-02-22
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for the quarter ending 2021-09-30 was $2.39M, a 7.86% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for the quarter ending 2021-06-30 was $76.00K, a 96.19% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for the quarter ending 2021-03-31 was $1.09M, a 153.83% increase year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for the quarter ending 2020-12-31 was -$4.92M, a 361.72% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for fiscal 2020 was $100.00K, a 97.63% decline from fiscal 2019.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for fiscal 2019 was $4.22M, a 73.21% increase from fiscal 2018.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for fiscal 2018 was $2.43M.
- Tandem Diabetes Care, Inc. increase (decrease) in other current liabilities for fiscal 2017 was -$432.00K, a 175.39% decline from fiscal 2016.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 3 month as first filed | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 6 month as first filed | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 9 month as first filed | Increase (Decrease) in Other Current Liabilities 12 month | Increase (Decrease) in Other Current Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.47M derived: sum of 2 quarters · filed 2021-11-03 | $3.56M 10-Q · filed 2021-11-03 | -$1.36M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.17M 10-Q · filed 2021-08-04 | -$3.75M derived: sum of 3 quarters · filed 2023-02-22 | -$1.16M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $1.09M 10-Q · filed 2021-05-05 | -$3.83M derived: sum of 2 quarters · filed 2023-02-22 | -$1.23M derived: sum of 3 quarters · filed 2023-02-22 | $763.00K derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$2.33M derived: sum of 2 quarters · filed 2023-02-22 | -$331.00K derived: sum of 3 quarters · filed 2023-02-22 | $100.00K 10-K · filed 2023-02-22 | $5.79M 10-K · filed 2021-02-24 | |||
| 2020-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $4.59M derived: sum of 2 quarters · filed 2021-11-03 | $5.02M 10-Q · filed 2021-11-03 | $6.90M derived: sum of 4 quarters · filed 2021-11-03 | ||||
| 2020-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.43M 10-Q · filed 2021-08-04 | $4.31M derived: sum of 3 quarters · filed 2021-08-04 | $7.69M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | $431.00K 10-Q · filed 2021-05-05 | $2.31M derived: sum of 2 quarters · filed 2021-05-05 | $5.70M derived: sum of 3 quarters · filed 2021-05-05 | $6.77M derived: sum of 4 quarters · filed 2021-05-05 | ||||
| 2019-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $5.27M derived: sum of 2 quarters · filed 2021-02-24 | $6.34M derived: sum of 3 quarters · filed 2021-02-24 | $4.22M 10-K · filed 2021-02-24 | ||||
| 2019-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.46M derived: sum of 2 quarters · filed 2020-11-05 | $2.33M 10-Q · filed 2020-11-05 | $3.67M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$1.05M 10-Q · filed 2020-07-30 | $284.00K derived: sum of 3 quarters · filed 2021-02-24 | $1.43M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | -$2.12M 10-Q · filed 2020-04-30 | -$786.00K derived: sum of 2 quarters · filed 2021-02-24 | $363.00K derived: sum of 3 quarters · filed 2021-02-24 | $670.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.48M derived: sum of 2 quarters · filed 2021-02-24 | $2.79M derived: sum of 3 quarters · filed 2021-02-24 | $2.43M 10-K · filed 2021-02-24 | $3.22M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $1.46M derived: sum of 2 quarters · filed 2019-11-04 | $1.10M 10-Q · filed 2019-11-04 | $1.27M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$49.00K 10-Q · filed 2019-08-01 | $120.00K derived: sum of 3 quarters · filed 2020-02-24 | $369.00K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | -$356.00K 10-Q · filed 2019-04-30 | -$187.00K derived: sum of 2 quarters · filed 2020-02-24 | $62.00K derived: sum of 3 quarters · filed 2020-02-24 | -$406.00K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $418.00K derived: sum of 2 quarters · filed 2020-02-24 | -$50.00K derived: sum of 3 quarters · filed 2020-02-24 | -$432.00K 10-K · filed 2020-02-24 | $260.00K 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$219.00K derived: sum of 2 quarters · filed 2018-11-01 | -$601.00K 10-Q · filed 2018-11-01 | -$1.38M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$468.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | -$850.00K 10-Q · filed 2018-07-30 | -$1.63M derived: sum of 3 quarters · filed 2019-02-26 | -$680.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$382.00K 10-Q · filed 2018-04-26 | -$1.16M derived: sum of 2 quarters · filed 2019-02-26 | -$212.00K derived: sum of 3 quarters · filed 2019-02-26 | $330.00K derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$775.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $170.00K derived: sum of 2 quarters · filed 2019-02-26 | $712.00K derived: sum of 3 quarters · filed 2019-02-26 | $573.00K 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $945.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $1.49M derived: sum of 2 quarters · filed 2017-10-26 | $1.35M 10-Q · filed 2017-10-26 | $3.08M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $542.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $403.00K 10-Q · filed 2017-07-27 | $2.13M derived: sum of 3 quarters · filed 2018-03-01 | $2.37M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | -$139.00K 10-Q · filed 2017-04-27 | $1.59M derived: sum of 2 quarters · filed 2018-03-01 | $1.83M derived: sum of 3 quarters · filed 2018-03-01 | $1.95M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.97M derived: sum of 2 quarters · filed 2018-03-01 | $2.08M derived: sum of 3 quarters · filed 2018-03-01 | $1.92M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $242.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $355.00K derived: sum of 2 quarters · filed 2016-11-01 | $195.00K 10-Q · filed 2016-11-01 | $442.00K derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$47.00K 10-Q · filed 2016-07-28 | $200.00K derived: sum of 3 quarters · filed 2017-03-08 | -$381.00K derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-03-31 | -$160.00K 10-Q · filed 2016-04-28 | $87.00K derived: sum of 2 quarters · filed 2017-03-08 | -$494.00K derived: sum of 3 quarters · filed 2017-03-08 | -$459.00K derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2014-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | -$334.00K derived: sum of 2 quarters · filed 2017-03-08 | -$299.00K derived: sum of 3 quarters · filed 2017-03-08 | -$1.57M 10-K · filed 2017-03-08 | ||||
| 2014-09-30 | -$581.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$546.00K derived: sum of 2 quarters · filed 2015-10-29 | -$1.82M 10-Q · filed 2015-10-29 | -$1.82M 10-Q · filed 2014-11-06 | -$2.24M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$1.24M 10-Q · filed 2015-07-30 | -$1.24M 10-Q · filed 2014-07-31 | -$1.66M derived: sum of 3 quarters · filed 2016-02-24 | -$685.13K derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | -$1.28M 10-Q · filed 2015-04-30 | -$1.28M 10-Q · filed 2014-05-06 | -$1.70M derived: sum of 2 quarters · filed 2016-02-24 | -$720.13K derived: sum of 3 quarters · filed 2016-02-24 | -$2.86M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | -$420.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $555.87K derived: sum of 2 quarters · filed 2016-02-24 | -$1.59M derived: sum of 3 quarters · filed 2016-02-24 | $895.00K 10-K · filed 2016-02-24 | ||||
| 2013-09-30 | $976.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.17M derived: sum of 2 quarters · filed 2014-11-06 | $1.32M 10-Q · filed 2014-11-06 | |||||
| 2013-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $339.13K 10-Q · filed 2014-07-31 | ||||||
| 2013-03-31 | $2.48M 10-Q · filed 2014-05-06 | |||||||
| 2012-12-31 | $2.34M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |